Initiation of glucose-lowering drugs reduces the anticoagulant effect of warfarin-But not through altered drug metabolism in patients with type 2 diabetes.
Dunvald AD, Nielsen F, Olsen DA, Ernst MT, Donnelly L, Soto-Pedre E, Kristiansen MR, Nielsen JS, Persson F, Højlund K, Madsen JS, Søndergaard J, Pearson E, Pottegård A, Stage TB.
Dunvald AD, et al. Among authors: madsen js.
Br J Clin Pharmacol. 2023 Aug;89(8):2529-2541. doi: 10.1111/bcp.15725. Epub 2023 Apr 14.
Br J Clin Pharmacol. 2023.
PMID: 36967527
Free article.